These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27340023)

  • 21. Response to "Effect of tissue plasminogen activator dose and interval on stroke severity".
    Sahlas DJ; Gould L; Swartz R; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):198. PubMed ID: 24291015
    [No Abstract]   [Full Text] [Related]  

  • 22. 2006: a stroke odyssey.
    Tomsick TA
    AJNR Am J Neuroradiol; 2006; 27(10):2019-21. PubMed ID: 17110658
    [No Abstract]   [Full Text] [Related]  

  • 23. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.
    Anderson CS; Robinson T; Lindley RI; Arima H; Lavados PM; Lee TH; Broderick JP; Chen X; Chen G; Sharma VK; Kim JS; Thang NH; Cao Y; Parsons MW; Levi C; Huang Y; Olavarría VV; Demchuk AM; Bath PM; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Ricci S; Roffe C; Pandian J; Billot L; Woodward M; Li Q; Wang X; Wang J; Chalmers J;
    N Engl J Med; 2016 Jun; 374(24):2313-23. PubMed ID: 27161018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistical analysis plan for evaluating low- vs. standard-dose alteplase in the ENhanced Control of Hypertension and Thrombolysis strokE stuDy (ENCHANTED).
    Anderson CS; Woodward M; Arima H; Chen X; Lindley RI; Wang X; Chalmers J;
    Int J Stroke; 2015 Dec; 10(8):1313-5. PubMed ID: 26283139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of a medicolegal approach in clinical stalemates.
    Tang M
    J Med Ethics; 2012 Nov; 38(11):645-6. PubMed ID: 22923440
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in acute ischemic stroke.
    Loh PK; Sharma VK
    Stroke; 2010 Mar; 41(3):e164; author reply 165. PubMed ID: 20110536
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department.
    ; Brown MD; Burton JH; Nazarian DJ; Promes SB
    Ann Emerg Med; 2015 Sep; 66(3):322-333.e31. PubMed ID: 26304253
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.
    Wardlaw JM; Koumellis P; Liu M
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000514. PubMed ID: 23728633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analysis.
    Stroke Thrombolysis Trialists' Collaborative Group
    Int J Stroke; 2013 Jun; 8(4):278-83. PubMed ID: 23639145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study): How Low Can We Go With Intravenous Tissue-Type Plasminogen Activator Dose and Blood Pressure Level?
    Strbian D; Saposnik G
    Stroke; 2016 Dec; 47(12):3063-3064. PubMed ID: 27789665
    [No Abstract]   [Full Text] [Related]  

  • 31. Low-dose versus standard-dose alteplase in acute ischemic stroke in Asian stroke registries: an individual patient data pooling study.
    Wang X; Li J; Moullaali TJ; Lee KJ; Kim BJ; Bae HJ; Wang A; Wang Y; Wang DZ; Wang Y; Kumamoto M; Toyoda K; Koga M; Sato S; Yoshimura S; Sui Y; Xu B; Xiao Y; Lee TH; Liou CW; Lee JD; Peng TI; Huang YC; Paliwal PR; Sharma M; Escabillas C; Navarro JC; Sun MC; Dong Y; Dong Q; Anderson CS; Sharma VK
    Int J Stroke; 2019 Oct; 14(7):670-677. PubMed ID: 31226919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous Splenic Rupture Following Intravenous Thrombolysis with Alteplase Applied as Stroke Therapy - Case Report and Review of Literature.
    Aleksic-Shihabi A; Jadrijevic E; Milekic N; Bulicic AR; Titlic M; Suljic E
    Med Arch; 2016 Feb; 70(1):69-71. PubMed ID: 26980937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Kumar G; Uhrig D; Fowler S; DeLaney MC; Alexandrov AV
    CNS Drugs; 2015 Aug; 29(8):659-67. PubMed ID: 26251162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteplase in acute ischaemic stroke: the need for speed.
    Hill MD; Coutts SB
    Lancet; 2014 Nov; 384(9958):1904-6. PubMed ID: 25106064
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of national guidelines while staying abroad with an acute stroke.
    Okazaki S; Fatar M
    Cerebrovasc Dis; 2014; 38(3):161-2. PubMed ID: 25300432
    [No Abstract]   [Full Text] [Related]  

  • 36. Alteplase Therapy for Acute Ischemic Stroke in Pregnancy: Two Case Reports and a Systematic Review of the Literature.
    Ryman KM; Pace WD; Smith S; Fontaine GV
    Pharmacotherapy; 2019 Jul; 39(7):767-774. PubMed ID: 31077601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-arterial Therapy in the Early Treatment of Acute Ischaemic Stroke.
    Kappelle LJ; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):1-2. PubMed ID: 26363971
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
    Takeuchi S; Wada K; Nagatani K; Otani N; Osada H; Nawashiro H
    Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979
    [No Abstract]   [Full Text] [Related]  

  • 39. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
    Parsons M; Spratt N; Bivard A; Campbell B; Chung K; Miteff F; O'Brien B; Bladin C; McElduff P; Allen C; Bateman G; Donnan G; Davis S; Levi C
    N Engl J Med; 2012 Mar; 366(12):1099-107. PubMed ID: 22435369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
    Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.